HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong Wang Selected Research

DNA-(Apurinic or Apyrimidinic Site) Lyase (AP Endonuclease)

12/2011Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells.
11/2009Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
12/2007Vector-based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo.
6/2004Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong Wang Research Topics

Disease

464Neoplasms (Cancer)
12/2022 - 03/2002
125Inflammation (Inflammations)
12/2022 - 12/2004
83Neoplasm Metastasis (Metastasis)
04/2022 - 08/2007
70Infections
11/2022 - 01/2005
52Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 11/2009
52Breast Neoplasms (Breast Cancer)
01/2022 - 03/2007
48Hepatocellular Carcinoma (Hepatoma)
06/2022 - 12/2007
42Stomach Neoplasms (Stomach Cancer)
02/2022 - 11/2007
36Lung Neoplasms (Lung Cancer)
06/2022 - 08/2007
34Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 07/2005
34Hypoxia (Hypoxemia)
01/2022 - 12/2007
29Fibrosis (Cirrhosis)
12/2022 - 04/2007
29Pain (Aches)
06/2022 - 07/2005
27Prostatic Neoplasms (Prostate Cancer)
01/2022 - 08/2003
26Carcinoma (Carcinomatosis)
02/2022 - 01/2007
25Carcinogenesis
07/2022 - 10/2004
25Wounds and Injuries (Trauma)
06/2022 - 07/2007
23Type 2 Diabetes Mellitus (MODY)
12/2022 - 01/2006
22Body Weight (Weight, Body)
12/2022 - 03/2004
22Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 03/2002
20Necrosis
07/2022 - 12/2005
20Myocardial Infarction
03/2022 - 12/2004
20Ischemia
01/2021 - 12/2005
18Stroke (Strokes)
03/2022 - 10/2006
18Glioma (Gliomas)
01/2022 - 10/2004
18Liver Neoplasms (Liver Cancer)
01/2022 - 12/2007
18Insulin Resistance
01/2022 - 01/2006
17Hemorrhage
11/2022 - 03/2005
17Renal Cell Carcinoma (Grawitz Tumor)
03/2022 - 05/2009
17Heart Failure
02/2022 - 04/2010
17Rheumatoid Arthritis
01/2022 - 07/2002
17Reperfusion Injury
05/2021 - 05/2006
16Obesity
12/2022 - 01/2006
16Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 10/2008
16Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 11/2009
16Arthritis (Polyarthritis)
11/2021 - 10/2004
15Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 01/2006
15Hematoma
03/2022 - 10/2006
15Adenocarcinoma
01/2022 - 01/2003
15Melanoma (Melanoma, Malignant)
09/2021 - 03/2014
15Adenocarcinoma of Lung
03/2021 - 11/2002
14Hypertension (High Blood Pressure)
04/2022 - 10/2006
14Schizophrenia (Dementia Praecox)
01/2022 - 08/2012
14Disease Progression
01/2022 - 02/2013
13Chronic Subdural Hematoma
09/2022 - 01/2014
13Pneumonia (Pneumonitis)
06/2022 - 01/2012
13Atherosclerosis
06/2022 - 12/2004
13Osteoporosis
01/2022 - 11/2005
13Pulmonary Hypertension
06/2021 - 07/2011

Drug/Important Bio-Agent (IBA)

159Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2002
75Biomarkers (Surrogate Marker)IBA
07/2022 - 11/2011
67Pharmaceutical PreparationsIBA
12/2022 - 05/2004
61MicroRNAs (MicroRNA)IBA
12/2022 - 10/2009
53DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2003
44Glucose (Dextrose)FDA LinkGeneric
02/2022 - 05/2004
42Messenger RNA (mRNA)IBA
02/2022 - 06/2009
38Biological ProductsIBA
01/2022 - 11/2002
34CytokinesIBA
06/2022 - 12/2005
31Dexamethasone (Maxidex)FDA LinkGeneric
09/2022 - 01/2007
30RNA (Ribonucleic Acid)IBA
12/2022 - 03/2004
29Small Interfering RNA (siRNA)IBA
11/2021 - 06/2004
27Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 03/2002
27Cisplatin (Platino)FDA LinkGeneric
12/2020 - 05/2004
26Therapeutic UsesIBA
12/2022 - 01/2011
26Long Noncoding RNAIBA
06/2022 - 04/2016
26EnzymesIBA
06/2022 - 07/2002
24Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 12/2005
24EndonucleasesIBA
07/2021 - 01/2007
23LipidsIBA
12/2022 - 06/2009
23Atorvastatin (Lipitor)FDA Link
09/2022 - 01/2012
23ProdrugsIBA
01/2022 - 01/2010
22AntioxidantsIBA
06/2022 - 12/2011
21LigandsIBA
04/2022 - 10/2004
20Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 09/2009
19Peptides (Polypeptides)IBA
06/2022 - 03/2010
19Interleukin-6 (Interleukin 6)IBA
06/2022 - 01/2008
17Phosphotransferases (Kinase)IBA
12/2022 - 06/2011
17AntigensIBA
06/2022 - 01/2007
171-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2022 - 01/2010
16CateninsIBA
06/2022 - 06/2015
15Indicators and Reagents (Reagents)IBA
09/2022 - 04/2010
15hydroxypropyl methacrylateIBA
10/2020 - 07/2006
14Immunoglobulin G (IgG)IBA
01/2022 - 11/2010
14salicylhydroxamic acid (SHAM)IBA
01/2022 - 12/2005
13Transcription Factors (Transcription Factor)IBA
02/2022 - 01/2010
13PlatinumIBA
01/2022 - 05/2004
13Insulin (Novolin)FDA Link
01/2022 - 01/2006
13GlucocorticoidsIBA
01/2022 - 07/2012

Therapy/Procedure

182Therapeutics
12/2022 - 03/2002
78Drug Therapy (Chemotherapy)
06/2022 - 04/2005
28Precision Medicine
05/2022 - 01/2014
27Immunotherapy
05/2022 - 09/2011
25Radiotherapy
12/2022 - 04/2005
19Transplantation
01/2022 - 03/2005
18Photochemotherapy (Photodynamic Therapy)
05/2022 - 01/2010
16Percutaneous Coronary Intervention
03/2022 - 01/2015
15Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 04/2013
14Ligation
01/2022 - 04/2007
13Length of Stay
03/2022 - 01/2013
13Aftercare (After-Treatment)
01/2022 - 10/2009